Pre-order Enquiry
Request Free Sample
Global Femoral Cannula Market Research Report 2021
SKU ID : QYR-17324920 | Publishing Date : 04-Feb-2021 | No. of pages : 91
Femoral arteriovenous cannula provides temporary support for extracorporeal circulation and gas exchange to replace heart or lung function as a bridge for resuscitation or other long-term support.
When intubated through the femoral and internal jugular veins, blood is drawn through the femoral or internal jugular vein catheter and pumped through membrane oxygenators to remove carbon dioxide, increase oxygen, and provide temperature control.
Partial to complete extracorporeal lung support is provided to maintain adequate oxygenation and normal blood flow.
Globally, major manufacturers of femoral arteriovenous systems include Medtronic, Edward Lifescience, LivaNova, Surge Cardiovascular, Kangxin, Xenios AG, and Chalice Medical.
The main producers are mainly in Europe and the United States.
The global Femoral Cannula market was valued at US$ 31 million in 2019 and is expected to reach US$ 46 million by the end of 2026, growing at a CAGR of 5.7% during 2021-2026.
This report focuses on Femoral Cannula volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Femoral Cannula market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Femoral Cannula Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Unipolar
Bipolar
Segment by Application
Traditional extracorporeal circulation surgery
Extracorporeal membrane oxygenation (ECMO)
Hemodialysis
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Medtronic
Edward Lifescience
LivaNova
Surge Cardiovascular
Changzhou KangXin Medical Instruments Co., Ltd.
Chalice Medical Ltd.
Xenios AG
When intubated through the femoral and internal jugular veins, blood is drawn through the femoral or internal jugular vein catheter and pumped through membrane oxygenators to remove carbon dioxide, increase oxygen, and provide temperature control.
Partial to complete extracorporeal lung support is provided to maintain adequate oxygenation and normal blood flow.
Globally, major manufacturers of femoral arteriovenous systems include Medtronic, Edward Lifescience, LivaNova, Surge Cardiovascular, Kangxin, Xenios AG, and Chalice Medical.
The main producers are mainly in Europe and the United States.
The global Femoral Cannula market was valued at US$ 31 million in 2019 and is expected to reach US$ 46 million by the end of 2026, growing at a CAGR of 5.7% during 2021-2026.
This report focuses on Femoral Cannula volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Femoral Cannula market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Femoral Cannula Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Unipolar
Bipolar
Segment by Application
Traditional extracorporeal circulation surgery
Extracorporeal membrane oxygenation (ECMO)
Hemodialysis
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Medtronic
Edward Lifescience
LivaNova
Surge Cardiovascular
Changzhou KangXin Medical Instruments Co., Ltd.
Chalice Medical Ltd.
Xenios AG
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
